NEW YORK (TheStreet) -- Agilent Technologies (A) stock is falling in post-market trading after the maker of bio-analytic equipment posted second-quarter earnings slightly short of analysts' estimates. After the bell, shares had slipped 1.5% to $55.01.
Over the three months to April, the company earned 72 cents a share, a penny less than analysts surveyed by Thomson Reuters expected. Revenue of $1.73 billion was inline with analysts' estimates.
For its third quarter, management guided for revenue of $1.74 billion to $1.76 billion with adjusted net income between 72 cents and 74 cents a share. Analysts expected 79 cents a share and revenue of $1.74 billion.
Must Read: Warren Buffett's 10 Favorite Growth Stocks
TheStreet Ratings team rates AGILENT TECHNOLOGIES INC as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate AGILENT TECHNOLOGIES INC (A) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity."